Jo Park

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng, Tae Won Kim, Johanna C. Bendell et al. · The Lancet Oncology · 2019 · 543 citations · Full text

Cobimetinib Versus Regorafenib, Oncology, Medicine +10

Production of leucinostatins and nematicidal activity of Australian isolates of Paecilomyces lilacinus (Thom) Samson

Jo Park, Jaih Hargreaves, E.J. McConville et al. · Letters in Applied Microbiology · 2004 · 129 citations

An unusual presentation of aggressive epithelial-myoepithelial carcinoma of the nasal cavity with high-grade histology

Jo Park, Chan Kwon Jung, Di Hua Sun et al. · The Journal of Laryngology & Otology · 2011 · 22 citations

Surgical morbidity and mortality in patients after microvascular reconstruction for head and neck cancer

Young Hoon Joo, K‐J. Cho, Jo Park et al. · Clinical Otolaryngology · 2017 · 19 citations

Solid state steelmaking by decarburisation of rapidly solidified high carbon iron sheet

Lee Wh, Jo Park, Lee Js et al. · Ironmaking & Steelmaking Processes Products and Applications · 2012 · 17 citations